As Executive Vice President and Chief Financial and Business Officer, Jay Mohr provides financial leadership and business development to the organization and is responsible for managing the financial, business development, and facilities operations of NYBC.
Jay brings over 27 years of successful executive leadership in the biopharmaceutical industry. Before joining NYBC, Jay served as the Chief Operating and Business Officer of AZTherapies, a privately held biopharma company focused on neurodegenerative diseases. At AZTherapies, Jay implemented financing and business development initiatives, developed and executed corporate strategy, and managed investor relations.
Having previously served as CEO of several pharma and life science companies, Jay has vast experience in capital formation, P&L management, and corporate and business development, and in these roles his efforts generated significant shareholder value. He co-founded Dirigo Therapeutics, Locust Walk Partners, and Gloucester Pharmaceuticals. Jay currently serves on the boards of the T1D Exchange, the Maine Technological Institute, and the Leonard Davis Institute of Healthcare Economics at the University of Pennsylvania.
Jay graduated from Vanderbilt University with a Bachelor of Arts in Economics and German. He received his Master of Business Administration from The Wharton School of the University of Pennsylvania.